Achillion promotes Joseph Truitt to senior VP
This article was originally published in Scrip
Executive Summary
Achillion, an innovative pharma company developing treatments for infectious disease, has made Joseph Truitt senior vice-president of business development. Mr Truitt maintains his current position as chief commercial officer, having previously served as vice-president of business development.
You may also be interested in...
Almirall launches Constella in six European markets
Almirall has launched its irritable bowel syndrome drug Constella (linaclotide) in six European countries, with several other launches planned for later this year.
Dermira raises $35m in series B
Dermira, a dermatology-focused biotech, has raised $35m in a series B financing.
Clovis ups public offering to $240m
Clovis Oncology has raised its public offering, announced 11 June, from $170m to $240m.